CURR - CURE Pharmaceutical posts results from initial trials of erectile dysfunction product

CURE Pharmaceutical (CURR) announces successful results from initial clinical trials for erectile dysfunction product CUREfilm Blue.CUREfilm Blue utilizes the company’s patented and proprietary fast-dissolving drug delivery platform, known as CUREfilm, to deliver the active pharmaceutical ingredient ((API)) sildenafil citrate.CURE will now advance its clinical program with the objective of U.S. Food and Drug Administration ((FDA)) approval, the company said.

For further details see:

CURE Pharmaceutical posts results from initial trials of erectile dysfunction product